These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35328466)

  • 1. Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.
    Liu CJ; Tsai YS; Huang HS
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
    Khan SR; Glenton PA; Byer KJ
    Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats.
    Zuo J; Khan A; Glenton PA; Khan SR
    Nephrol Dial Transplant; 2011 Jun; 26(6):1785-96. PubMed ID: 21378157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition.
    Tsuji H; Shimizu N; Nozawa M; Umekawa T; Yoshimura K; De Velasco MA; Uemura H; Khan SR
    Urolithiasis; 2014 Jun; 42(3):195-202. PubMed ID: 24619192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multifunctional character of osteopontin and strategy for clinical applications].
    Tsuji H; Umekawa T; Uemura H
    Hinyokika Kiyo; 2011 Jan; 57(1):49-54. PubMed ID: 21304262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II receptor blockage on osteopontin expression and calcium oxalate crystal deposition in rat kidneys.
    Umekawa T; Hatanaka Y; Kurita T; Khan SR
    J Am Soc Nephrol; 2004 Mar; 15(3):635-44. PubMed ID: 14978165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys.
    Khan SR; Glenton PA
    J Urol; 1995 Mar; 153(3 Pt 1):811-7. PubMed ID: 7861545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
    Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
    Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Sodium-Induced Oxidative Stress and Poor Anticrystallization Defense Aggravate Calcium Oxalate Crystal Formation in Rat Hyperoxaluric Kidneys.
    Huang HS; Ma MC
    PLoS One; 2015; 10(8):e0134764. PubMed ID: 26241473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total flavonoids of Desmodium styracifolium attenuates the formation of hydroxy-L-proline-induced calcium oxalate urolithiasis in rats.
    Zhou J; Jin J; Li X; Zhao Z; Zhang L; Wang Q; Li J; Zhang Q; Xiang S
    Urolithiasis; 2018 Jun; 46(3):231-241. PubMed ID: 28567512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a two-stage model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 2 in vivo studies of stone growth on biomimetic Randall's plaque.
    O'Kell AL; Lovett AC; Canales BK; Gower LB; Khan SR
    Urolithiasis; 2019 Aug; 47(4):335-346. PubMed ID: 30218116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
    Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
    Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney.
    Hirose Y; Yasui T; Taguchi K; Fujii Y; Niimi K; Hamamoto S; Okada A; Kubota Y; Kawai N; Itoh Y; Tozawa K; Sasaki S; Kohri K
    Urolithiasis; 2013 Aug; 41(4):279-94. PubMed ID: 23754513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.
    Wesson JA; Johnson RJ; Mazzali M; Beshensky AM; Stietz S; Giachelli C; Liaw L; Alpers CE; Couser WG; Kleinman JG; Hughes J
    J Am Soc Nephrol; 2003 Jan; 14(1):139-47. PubMed ID: 12506146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF-κB and NLRP3 inflammasome.
    Sun Y; Liu Y; Guan X; Kang J; Wang X; Liu Q; Li D; Xu H; Tao Z; Deng Y
    IUBMB Life; 2020 May; 72(5):1065-1074. PubMed ID: 32083808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition.
    Huang HS; Ma MC; Chen J
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F388-96. PubMed ID: 18448592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.